264 related articles for article (PubMed ID: 12377564)
1. The impact of genomics on anti-infectives drug discovery and development.
Parkinson T
Trends Microbiol; 2002; 10(10 Suppl):S22-6. PubMed ID: 12377564
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenomics: the implementation phase.
Sadee W
AAPS PharmSci; 2002; 4(2):E5. PubMed ID: 12141268
[TBL] [Abstract][Full Text] [Related]
3. [Drug discovery based on genomic information].
Nohmi T
Rinsho Byori; 2002 Jul; 50(7):694-7. PubMed ID: 12187707
[TBL] [Abstract][Full Text] [Related]
4. Alternative strategies in drug development: clinical pharmacological aspects.
Kuhlmann J
Int J Clin Pharmacol Ther; 1999 Dec; 37(12):575-83. PubMed ID: 10599949
[TBL] [Abstract][Full Text] [Related]
5. Progress in pharmacogenomics and its promise for medicine.
Blake CA; Sobel BE
Exp Biol Med (Maywood); 2008 Dec; 233(12):1482-3. PubMed ID: 18849537
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenetics and pharmacogenomics of sexual dysfunction: current status, gaps and potential applications.
Abdel-Hamid IA; Andersson KE
Pharmacogenomics; 2009 Oct; 10(10):1625-44. PubMed ID: 19842936
[TBL] [Abstract][Full Text] [Related]
7. Chemical genomics: a systematic approach in biological research and drug discovery.
Zheng XF; Chan TF
Curr Issues Mol Biol; 2002 Apr; 4(2):33-43. PubMed ID: 11931568
[TBL] [Abstract][Full Text] [Related]
8. Life in the fast lane: high-throughput chemistry for lead generation and optimisation.
Hunter D
J Cell Biochem Suppl; 2001; Suppl 37():22-7. PubMed ID: 11842424
[TBL] [Abstract][Full Text] [Related]
9. The era of genomics: impact on sepsis clinical trial design.
Cariou A; Chiche JD; Charpentier J; Dhainaut JF; Mira JP
Crit Care Med; 2002 May; 30(5 Suppl):S341-8. PubMed ID: 12004257
[TBL] [Abstract][Full Text] [Related]
10. Implications of pharmacogenomics for drug development.
Kirk RJ; Hung JL; Horner SR; Perez JT
Exp Biol Med (Maywood); 2008 Dec; 233(12):1484-97. PubMed ID: 18849536
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetics in drug development.
McCarthy AD; Kennedy JL; Middleton LT
Philos Trans R Soc Lond B Biol Sci; 2005 Aug; 360(1460):1579-88. PubMed ID: 16096107
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenomics: translating functional genomics into rational therapeutics.
Evans WE; Relling MV
Science; 1999 Oct; 286(5439):487-91. PubMed ID: 10521338
[TBL] [Abstract][Full Text] [Related]
13. With your genes? Take one of these, three times a day.
Abbott A
Nature; 2003 Oct; 425(6960):760-2. PubMed ID: 14574377
[No Abstract] [Full Text] [Related]
14. Workshop outcomes report: initiatives to establish a European Network of pharmacogenetics/genomics and progress.
Maitland-van der Zee AH; Aitchison K; Kirchheiner J;
Eur J Pharm Sci; 2007 Jul; 31(3-4):151-5. PubMed ID: 17452095
[No Abstract] [Full Text] [Related]
15. Timely synthetic support for medicinal chemists.
Potoski J
Drug Discov Today; 2005 Jan; 10(2):115-20. PubMed ID: 15718160
[TBL] [Abstract][Full Text] [Related]
16. Drug discovery conference 2008. Small-Molecule Drug Discovery: From Early Stage to the Clinic.
Terrett NK
IDrugs; 2008 Mar; 11(3):164-8. PubMed ID: 18311648
[No Abstract] [Full Text] [Related]
17. Moving towards individualized medicine with pharmacogenomics.
Evans WE; Relling MV
Nature; 2004 May; 429(6990):464-8. PubMed ID: 15164072
[TBL] [Abstract][Full Text] [Related]
18. The inadequacy of the reductionist approach in discovering new therapeutic agents against complex diseases.
Duval MX
Exp Biol Med (Maywood); 2018 Aug; 243(12):1004-1013. PubMed ID: 30089398
[TBL] [Abstract][Full Text] [Related]
19. Pharmacogenetics, pharmacogenomics, and cardiovascular therapeutics: the way forward.
Terra SG; Johnson JA
Am J Cardiovasc Drugs; 2002; 2(5):287-96. PubMed ID: 14727958
[TBL] [Abstract][Full Text] [Related]
20. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
